{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:06:56Z","timestamp":1791292016297,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.08.027","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:52:12Z","timestamp":1409273532000},"page":"345-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration"],"prefix":"10.1016","volume":"71","author":[{"given":"Elpida","family":"Tsika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Shi-Yan","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Dikeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Glauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gellhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Galter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Knott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.027_bb0165","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/hmg\/dds522","article-title":"GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2","volume":"22","author":"Biosa","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbadis.2008.09.015","article-title":"Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease","volume":"7","author":"Biskup","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.027_bb0240","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21019","article-title":"Localization of LRRK2 to membranous and vesicular structures in mammalian brain","volume":"60","author":"Biskup","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0215","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4\u2013JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2014.08.027_bb0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-4-34","article-title":"Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons","volume":"4","author":"Daher","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.08.027_bb0325","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/hmg\/dds057","article-title":"Neurodegenerative phenotypes in an A53T alpha-synuclein transgenic mouse model are independent of LRRK2","volume":"21","author":"Daher","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0310","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cell.2008.11.037","article-title":"Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells","volume":"136","author":"D'Angelo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.027_bb0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","article-title":"An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family","volume":"57","author":"Funayama","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbadis.2008.12.007","article-title":"Mendelian forms of Parkinson's disease","volume":"7","author":"Gasser","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.027_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of Lrrk2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0050","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson's disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.08.027_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.027_bb0120","doi-asserted-by":"crossref","DOI":"10.1042\/AN20090007","article-title":"Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions","volume":"1","author":"Greggio","year":"2009","journal-title":"ASN Neuro"},{"key":"10.1016\/j.nbd.2014.08.027_bb0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.027_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell\u2013cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease","volume":"2","author":"Gu","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.08.027_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case\u2013control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0036581","article-title":"High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain","volume":"7","author":"Herzig","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.027_bb0250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2006.04246.x","article-title":"Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain","volume":"100","author":"Higashi","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.027_bb0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1474-4422(08)70116-9","article-title":"LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case\u2013control genetic study","volume":"7","author":"Hulihan","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","author":"International Parkinson Disease Genomics","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.08.027_bb0285","doi-asserted-by":"crossref","first-page":"e34693","DOI":"10.1371\/journal.pone.0034693","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.027_bb0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.08.027_bb0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.08.027_bb0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.08.027_bb0180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0175","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0185","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.027_bb0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11557","article-title":"Progressive degeneration of human neural stem cells caused by pathogenic LRRK2","volume":"491","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.027_bb0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"MacLeod","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.027_bb0200","doi-asserted-by":"crossref","first-page":"1750-1326","DOI":"10.1186\/1750-1326-7-15","article-title":"The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities","volume":"7","author":"Maekawa","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.08.027_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.027_bb0275","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0040","first-page":"410","article-title":"Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease","volume":"365","author":"Nichols","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.08.027_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.08.027_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.027_bb0230","doi-asserted-by":"crossref","first-page":"13971","DOI":"10.1523\/JNEUROSCI.3799-09.2009","article-title":"Phosphorylation of ezrin\/radixin\/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis","volume":"29","author":"Parisiadou","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0155","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","article-title":"Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells","volume":"105","author":"Plowey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.027_bb0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","article-title":"Parkinsonism, Lrrk2 G2019S, and tau neuropathology","volume":"67","author":"Rajput","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.08.027_bb0195","doi-asserted-by":"crossref","first-page":"0018568","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.027_bb0320","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/ddr606","article-title":"PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity","volume":"21","author":"Ramonet","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0160","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/cb2002413","article-title":"Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons","volume":"6","author":"Ramsden","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874609811003020081","article-title":"Evidence for the involvement of lamins in aging","volume":"3","author":"Rodriguez","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and Lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0065","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0300","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.1127168","article-title":"Lamin A-dependent nuclear defects in human aging","volume":"312","author":"Scaffidi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.08.027_bb0070","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0130","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.027_bb0125","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.027_bb0260","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-213X-1-4","article-title":"Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus","volume":"1","author":"Srinivas","year":"2001","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pgen.1002526","article-title":"GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1","volume":"8","author":"Stafa","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0220","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.027_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11910-012-0265-8","article-title":"Mechanisms of LRRK2-mediated neurodegeneration","volume":"12","author":"Tsika","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2014.08.027_bb0115","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.25130","article-title":"Contribution of GTPase activity to LRRK2-associated Parkinson disease","volume":"4","author":"Tsika","year":"2013","journal-title":"Small GTPases"},{"key":"10.1016\/j.nbd.2014.08.027_bb0225","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/j.1742-4658.2007.05886.x","article-title":"Analysis of dopamine transporter gene expression pattern \u2014 generation of DAT-iCre transgenic mice","volume":"274","author":"Turiault","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2014.08.027_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0245","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/cne.23583","article-title":"Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents","volume":"522","author":"West","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0290","doi-asserted-by":"crossref","first-page":"a000760","DOI":"10.1101\/cshperspect.a000760","article-title":"Diseases of the nuclear envelope","volume":"2","author":"Worman","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0295","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2990.2006.00819.x","article-title":"Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress","volume":"33","author":"Woulfe","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.027_bb0145","doi-asserted-by":"crossref","first-page":"1000902","DOI":"10.1371\/journal.pgen.1000902","article-title":"GTPase activity plays a key role in the pathobiology of LRRK2","volume":"6","author":"Xiong","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2014.08.027_bb0315","series-title":"Current Protocols in Neuroscience\/Editorial Board, Jacqueline N. Crawley \u2026 [et al.]","article-title":"Simple Behavioral Assessment of Mouse Olfaction","author":"Yang","year":"2009"},{"key":"10.1016\/j.nbd.2014.08.027_bb0205","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7150\/ijbs.7.753","article-title":"Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake","volume":"7","author":"Zhou","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.nbd.2014.08.027_bb0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.027_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","article-title":"The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval","volume":"74","author":"Zimprich","year":"2004","journal-title":"Am. J. Hum. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T06:26:30Z","timestamp":1538288790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":65,"alternative-id":["S0969996114002587"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.027","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}